Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9241126 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Hodgkins Disease;   Non-Hodgkins Lymphoma;   Aplastic Anemia;   Multiple Myeloma;   Myelodysplastic Syndrome
Interventions: Drug: Busulfan;   Drug: Clofarabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine

Indicates status has not been verified in more than two years